Cargando…

218. IV to PO Conversion of Antimicrobials: Small Intervention, Big Impact

BACKGROUND: Appropriate conversions from intravenous (IV) to oral (PO) therapy early in the hospital stay can promote patient comfort and satisfaction while decreasing unnecessary costs and adverse events related to IV catheters. Although IV to PO conversion as a stewardship intervention is consider...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Wenjing, Mang, Norman, Ortwine, Jessica, Alvarez, Kristin, Prokesch, Bonnie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253346/
http://dx.doi.org/10.1093/ofid/ofy210.230
_version_ 1783373477917491200
author Wei, Wenjing
Mang, Norman
Ortwine, Jessica
Alvarez, Kristin
Prokesch, Bonnie
author_facet Wei, Wenjing
Mang, Norman
Ortwine, Jessica
Alvarez, Kristin
Prokesch, Bonnie
author_sort Wei, Wenjing
collection PubMed
description BACKGROUND: Appropriate conversions from intravenous (IV) to oral (PO) therapy early in the hospital stay can promote patient comfort and satisfaction while decreasing unnecessary costs and adverse events related to IV catheters. Although IV to PO conversion as a stewardship intervention is considered “low hanging fruit,” the time spent on review can be extensive and reporting can be challenging. Utilization of an automated decision support system allows for easy monitoring of IV to PO switches as well as identification of ways to enhance the efficiency and effectiveness of the program. The primary objective was improving IV to PO conversions through an automated system and measuring outcomes electronically without manual chart review. Desired metrics were percentage of eligible antimicrobials ordered as PO, number of conversions, and cost avoidance. METHODS: A protocol was approved by the Pharmacy and Therapeutics committee allowing pharmacists to auto-convert medications from IV to PO when meeting prespecified criteria. These identification criteria were implemented electronically using a traffic light decision support system to prioritize eligible patients (Figure 1). Education was provided both in person and as pocket cards with guidance on eligible antimicrobials for IV to PO conversions. Metrics were based on monthly antimicrobial utilization data and displayed as a dashboard (Figure 2). RESULTS: Monthly metrics provided the stewardship team feedback on the effectiveness of the IV to PO program and identified areas for improvement. From January 2017 to January 2018, cost avoidance from ordering PO as opposed to IV agents was $524,788 with 1,843 IV to PO conversions performed by both providers and pharmacists. A total of 65% of the eligible antimicrobials were ordered via the PO route. Based on these findings, a multifaceted approach to further expand the initiative was undertaken. CONCLUSION: The IV to PO decision support system improves the efficiency of IV to PO review process and reduces time spent reviewing charts of patients who do not meet criteria for conversion. The development of automated monthly metrics is an efficient method to assess the effectiveness of the program as well as identify key areas for future development. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6253346
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62533462018-11-28 218. IV to PO Conversion of Antimicrobials: Small Intervention, Big Impact Wei, Wenjing Mang, Norman Ortwine, Jessica Alvarez, Kristin Prokesch, Bonnie Open Forum Infect Dis Abstracts BACKGROUND: Appropriate conversions from intravenous (IV) to oral (PO) therapy early in the hospital stay can promote patient comfort and satisfaction while decreasing unnecessary costs and adverse events related to IV catheters. Although IV to PO conversion as a stewardship intervention is considered “low hanging fruit,” the time spent on review can be extensive and reporting can be challenging. Utilization of an automated decision support system allows for easy monitoring of IV to PO switches as well as identification of ways to enhance the efficiency and effectiveness of the program. The primary objective was improving IV to PO conversions through an automated system and measuring outcomes electronically without manual chart review. Desired metrics were percentage of eligible antimicrobials ordered as PO, number of conversions, and cost avoidance. METHODS: A protocol was approved by the Pharmacy and Therapeutics committee allowing pharmacists to auto-convert medications from IV to PO when meeting prespecified criteria. These identification criteria were implemented electronically using a traffic light decision support system to prioritize eligible patients (Figure 1). Education was provided both in person and as pocket cards with guidance on eligible antimicrobials for IV to PO conversions. Metrics were based on monthly antimicrobial utilization data and displayed as a dashboard (Figure 2). RESULTS: Monthly metrics provided the stewardship team feedback on the effectiveness of the IV to PO program and identified areas for improvement. From January 2017 to January 2018, cost avoidance from ordering PO as opposed to IV agents was $524,788 with 1,843 IV to PO conversions performed by both providers and pharmacists. A total of 65% of the eligible antimicrobials were ordered via the PO route. Based on these findings, a multifaceted approach to further expand the initiative was undertaken. CONCLUSION: The IV to PO decision support system improves the efficiency of IV to PO review process and reduces time spent reviewing charts of patients who do not meet criteria for conversion. The development of automated monthly metrics is an efficient method to assess the effectiveness of the program as well as identify key areas for future development. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6253346/ http://dx.doi.org/10.1093/ofid/ofy210.230 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Wei, Wenjing
Mang, Norman
Ortwine, Jessica
Alvarez, Kristin
Prokesch, Bonnie
218. IV to PO Conversion of Antimicrobials: Small Intervention, Big Impact
title 218. IV to PO Conversion of Antimicrobials: Small Intervention, Big Impact
title_full 218. IV to PO Conversion of Antimicrobials: Small Intervention, Big Impact
title_fullStr 218. IV to PO Conversion of Antimicrobials: Small Intervention, Big Impact
title_full_unstemmed 218. IV to PO Conversion of Antimicrobials: Small Intervention, Big Impact
title_short 218. IV to PO Conversion of Antimicrobials: Small Intervention, Big Impact
title_sort 218. iv to po conversion of antimicrobials: small intervention, big impact
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253346/
http://dx.doi.org/10.1093/ofid/ofy210.230
work_keys_str_mv AT weiwenjing 218ivtopoconversionofantimicrobialssmallinterventionbigimpact
AT mangnorman 218ivtopoconversionofantimicrobialssmallinterventionbigimpact
AT ortwinejessica 218ivtopoconversionofantimicrobialssmallinterventionbigimpact
AT alvarezkristin 218ivtopoconversionofantimicrobialssmallinterventionbigimpact
AT prokeschbonnie 218ivtopoconversionofantimicrobialssmallinterventionbigimpact